Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Haeberlein Samantha L. Budd | Director | 2024-12-19 | 12,000 | $1.71 | $20.52kBuy |
Ivana Magovcevicliebisch | President and CEO | 2024-12-19 | 5,000 | $1.68 | $8.40kBuy |
Ivana Magovcevicliebisch | President and CEO | 2024-12-18 | 5,000 | $1.67 | $8.35kBuy |
Ivana Magovcevicliebisch | President and CEO | 2024-12-05 | 5,000 | $2.34 | $11.70kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Atlas Venture Fund XII LP | 12.51% | 5,836,874 | $9.98M | Insider |
Atlas Venture Life Science Advisors LLC | 12.51% | 5,836,874 | $9.98M | Institution |
Bruce Booth | 12.51% | 5,836,874 | $9.98M | Insider |
Stefan Vitorovic | 10.77% | 5,027,465 | $8.60M | Insider |
Vida Ventures GP III LLC | 10.75% | 5,015,929 | $8.58M | Insider |
Northpond Ventures GP LLC | 9.03% | 4,214,498 | $7.21M | Insider |
Amgen Inc | 6.87% | 3,206,281 | $5.48M | Insider |
Siren LLC | 4.27% | 1,991,038 | $3.40M | Institution |
Bvf Inc | 3.89% | 1,813,633 | $3.10M | Institution |
Clay Thorp | 3.34% | 1,559,030 | $2.67M | Insider |